Home › Idiopathic Thrombocytopenic Purpura › District of Columbia
Pag-aaral pangklinika para sa Idiopathic Thrombocytopenic Purpura sa District of Columbia
6 pag-aaral para sa Idiopathic Thrombocytopenic Purpura ang naghahanap ng mga kalahok sa mga site sa District of Columbia.
Mga Lungsod sa District of Columbia
Opisyal na teksto ng pag-aaral (English)
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- MedStar Georgetown University Hospital, Washington D.C.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06721013A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06722235Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
- Georgetown University Medical Center, Washington D.C.
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07095127A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06948318OM336 in Autoimmune Cytopenias
- Medstar, Washington D.C.
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07083960A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Georgetown University Hospital, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 1, 2026 · NCT06544499Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.